| Record ID | marc_loc_2016/BooksAll.2016.part28.utf8:22416370:1022 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part28.utf8:22416370:1022?format=raw |
LEADER: 01022cam a22003254a 4500
001 99057200
003 DLC
005 20030603111430.0
008 991101s2000 txua b 001 0 eng c
010 $a 99057200
020 $a1587060264 (alk. paper)
035 $a(DNLM)100899607
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC271.I45$bP46 2000
082 00 $a616.99/406$221
060 10 $aQZ 267$bP4235 2000
245 00 $aPeptide-based cancer vaccines /$c[edited by] W. Martin Kast.
260 $aGeorgetown, Tex. : Landes Bioscience ;$aAustin, Tex. :$bEurekah.com,$cc2000.
300 $a239 p. :$bill. ;$c24 cm.
440 0 $aMedical intelligence unit ;$v24
504 $aIncludes bibliographical references and index.
650 0 $aCancer vaccines.
650 0 $aCancer$xImmunotherapy.
650 0 $aPeptide drugs.
650 12 $aCancer Vaccines.
650 12 $aNeoplasms$xdrug therapy.
650 22 $aImmunotherapy$xmethods.
650 22 $aPeptides$xtherapeutic use.
700 1 $aKast, W. Martin.